Global Irritable Bowel Syndrome (IBS) Market Data Survey Report 2025
![](/report_cover/10278/global-irritable-bowel-syndrome-ibs-market-data-survey-report-2025_en.gif)
SUMMARY
The global Irritable Bowel Syndrome (IBS) market will reach Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
The global Irritable Bowel Syndrome (IBS) market will reach Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
- Global market size and forecast
- Regional market size, production data and export & import
- Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
- Major Application
- Major Type
- Valeant Pharmaceuticals
- Allergan
- Takeda
- Sucampo Pharmaceuticals
- McNeil Consumer Healthcare
- Sebela Pharmaceuticals
- Sebela Pharmaceuticals
- IM HealthScience
- Women
- Men
- IBS-D Drug
- IBS-C Drug
- Others
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Valeant Pharmaceuticals
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Allergan
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Takeda
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sucampo Pharmaceuticals
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 McNeil Consumer Healthcare
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Sebela Pharmaceuticals
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sebela Pharmaceuticals
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 IM HealthScience
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Women
4.1.1 Overview
4.1.2 Women Market Size and Forecast
4.2 Men
4.2.1 Overview
4.2.2 Men Market Size and Forecast
5 MARKET BY TYPE
5.1 IBS-D Drug
5.1.1 Overview
5.1.2 IBS-D Drug Market Size and Forecast
5.2 IBS-C Drug
5.2.1 Overview
5.2.2 IBS-C Drug Market Size and Forecast
5.3 Others
5.3.1 Overview
5.3.2 Others Market Size and Forecast
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Valeant Pharmaceuticals
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Allergan
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Takeda
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sucampo Pharmaceuticals
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 McNeil Consumer Healthcare
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Sebela Pharmaceuticals
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sebela Pharmaceuticals
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 IM HealthScience
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Women
4.1.1 Overview
4.1.2 Women Market Size and Forecast
4.2 Men
4.2.1 Overview
4.2.2 Men Market Size and Forecast
5 MARKET BY TYPE
5.1 IBS-D Drug
5.1.1 Overview
5.1.2 IBS-D Drug Market Size and Forecast
5.2 IBS-C Drug
5.2.1 Overview
5.2.2 IBS-C Drug Market Size and Forecast
5.3 Others
5.3.1 Overview
5.3.2 Others Market Size and Forecast
6 CONCLUSION
LIST OF TABLES
Tab Regional Production 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Million USD)
Tab Sales Revenue, Cost and Margin of Valeant Pharmaceuticals
Tab Sales Revenue, Cost and Margin of Allergan
Tab Sales Revenue, Cost and Margin of Takeda
Tab Sales Revenue, Cost and Margin of Sucampo Pharmaceuticals
Tab Sales Revenue, Cost and Margin of McNeil Consumer Healthcare
Tab Sales Revenue, Cost and Margin of Sebela Pharmaceuticals
Tab Sales Revenue, Cost and Margin of Sebela Pharmaceuticals
Tab Sales Revenue, Cost and Margin of IM HealthScience
Tab Regional Production 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Million USD)
Tab Sales Revenue, Cost and Margin of Valeant Pharmaceuticals
Tab Sales Revenue, Cost and Margin of Allergan
Tab Sales Revenue, Cost and Margin of Takeda
Tab Sales Revenue, Cost and Margin of Sucampo Pharmaceuticals
Tab Sales Revenue, Cost and Margin of McNeil Consumer Healthcare
Tab Sales Revenue, Cost and Margin of Sebela Pharmaceuticals
Tab Sales Revenue, Cost and Margin of Sebela Pharmaceuticals
Tab Sales Revenue, Cost and Margin of IM HealthScience
LIST OF FIGURES
Fig Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2011-2017 (Million USD)
Fig Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Women Market Size and CAGR 2011-2017 (Million USD)
Fig Women Market Forecast and CAGR 2018-2025 (Million USD)
Fig Men Market Size and CAGR 2011-2017 (Million USD)
Fig Men Market Forecast and CAGR 2018-2025 (Million USD)
Fig IBS-D Drug Market Size and CAGR 2011-2017 (Million USD)
Fig IBS-D Drug Market Forecast and CAGR 2018-2025 (Million USD)
Fig IBS-C Drug Market Size and CAGR 2011-2017 (Million USD)
Fig IBS-C Drug Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2011-2017 (Million USD)
Fig Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Women Market Size and CAGR 2011-2017 (Million USD)
Fig Women Market Forecast and CAGR 2018-2025 (Million USD)
Fig Men Market Size and CAGR 2011-2017 (Million USD)
Fig Men Market Forecast and CAGR 2018-2025 (Million USD)
Fig IBS-D Drug Market Size and CAGR 2011-2017 (Million USD)
Fig IBS-D Drug Market Forecast and CAGR 2018-2025 (Million USD)
Fig IBS-C Drug Market Size and CAGR 2011-2017 (Million USD)
Fig IBS-C Drug Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)